1,528 results on '"Sheridan, Cormac"'
Search Results
2. A new class of mRNA drugs targets poison exons
3. Innovators want pills to treat sickle cell disease. Can they match gene therapy?
4. A second chance for plant biotechnology in Europe
5. Can single-cell biology realize the promise of precision medicine?
6. Can gene editing drive out HIV and hepatitis viruses from inside cells?
7. Drugs catch a ride through the blood–brain barrier
8. The world’s first CRISPR therapy is approved: who will receive it?
9. Unprecedented blood biomarker enables ALS drug approval
10. Why gene therapies must go virus-free
11. Genetic medicines aim straight for the heart
12. Shoot the messenger: RNA editing is here
13. Industry appetite for natural killer cells intensifies
14. For hemophilia and thalassemia, a new era of ‘one-and-done’ gene therapies has arrived
15. Repairing the eye
16. mRNA printers kick-start personalized medicines for all
17. RNA drugs lower lipoprotein(a) and genetically driven cholesterol
18. Topical herpesvirus gene therapy enters final lap
19. First COVID-19 DNA vaccine approved, others in hot pursuit
20. Sickle cell gene therapies approach watershed
21. COVID-19 vaccine makers chase variant-ready vaccines
22. Innovators target vaccines for variants and shortages in global South
23. Bispecific antibodies poised to deliver wave of cancer therapies
24. Oncologists greet Lumakras: the world’s first KRAS inhibitor
25. CRISPR therapies march into clinic, but genotoxicity concerns linger
26. Questions swirl around failures of disease-modifying Huntington’s drugs
27. Off-the-shelf, gene-edited CAR-T cells forge ahead, despite safety scare
28. Massive data initiatives and AI provide testbed for pandemic forecasting
29. COVID-19 spurs wave of innovative diagnostics
30. Convalescent serum lines up as first-choice treatment for coronavirus
31. Fast, portable tests come online to curb coronavirus pandemic
32. First small-molecule drug targeting RNA gains momentum
33. The world’s first CRISPR therapy is approved: who will receive it?
34. A reprieve from hemophilia A, but for how long?
35. Coronavirus and the race to distribute reliable diagnostics
36. Huntington’s antisense drug marches into clinic
37. Drugmakers turn sights on scarred lungs
38. Grail of RAS cancer drugs within reach
39. PCSK9-gene-silencing, cholesterol-lowering drug impresses
40. Nature Biotechnology’s academic spinouts of 2018
41. Publisher Correction: Sickle cell gene therapies approach watershed
42. COVID-19 testing turns to T cells
43. Publisher Correction: Oncologists greet Lumakras: the world’s first KRAS inhibitor
44. Investors keep the faith in cancer liquid biopsies
45. Pancreatic cancer provides testbed for first mechanotherapeutics
46. Billion-dollar deal propels RNAi to CNS frontier
47. Unicorn startup trawls databases for protective genetic modifiers
48. Drug developers switch gears to inhibit STING
49. Death by inflammation: drug makers chase the master controller
50. Publisher Correction: Questions swirl around failures of disease-modifying Huntington’s drugs
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.